W. MacNee (Edinburgh, United Kingdom), A. Agusti (Barcelona, Spain)
LATE-BREAKING ABSTRACT: GOLD 2011: Combined COPD assessment of patients from the European health-related quality of life study L. Adamek, P. Jones, G. Nadeau, N. Banik (Uxbridge, London, United Kingdom; Munich, Germany)
| |
Prediction of the clinical course of COPD using the old and the new GOLD classification P. Lange, J.L. Marott, M. Dahl, T.S. Ingebrigtsen, J. Vestbo, B. Nordestgaard (Copenhagen, Herlev, Denmark)
| |
Characteristics of GOLD 2011 grading system in the COPDGene cohort M. Han, M. Dransfield, D. Curran-Everett, A. Anzueto, F. Martinez, E. Silverman, J. Crapo, G. Washko, B. Make (Ann Arbor, Birmingham, Denver, Boston, San Antonio, United States Of America)
| |
Combined COPD assessment using the new GOLD guidelines A. Mackay, G. Donaldson, A. Patel, R. Singh, J. Hurst, J. Wedzicha (London, United Kingdom)
| |
Combined assessment according to the new GOLD guidelines and its relation to outcome in COPD D. Stolz, K. Kostikas, F. Blasi, B. Milenkovic, W. Boersma, J. Aerts, R. Louis, T. Welte, A. Lacoma, C. Prat, A. Scherr, J. Rakic, M. Pappalettera, G. Rohde, A. Torres, S. Hertel, S. Giersdorf, M. Tamm (Basel, Switzerland; Thessaloniki, Greece; Milan, Italy; Belgrade, Republic Of Serbia; Alkmaar, Breda, Maastricht, Netherlands; Liege, Belgium; Hanover, Hennigsdorf, Germany; Badalona, Barcelona, Spain)
| |
Differences in the recommended initial therapy of COPD according to GOLD guidelines 2006 and 2011 I. Vyshnyvetskyy, Y. Mostovoy, O. Onyshchenko (Donetsk, Vinnitsa, Ukraine)
| |
GOLD assessment of COPD patients: Impact of symptoms assessment choice H. Mullerova, N. Locantore, P. Jones (Uxbridge, London, United Kingdom; Research Triangle Park, United States Of America)
| |
Comparison of modified Medical Research Council (mMRC) dyspnoea scale cut point ≥1 with COPD assessment test (CAT) ≥10 to differentiate low and high symptom COPD patients P. Jones, L. Adamek, G. Nadeau, N. Banik (London, Uxbridge, United Kingdom; Munich, Germany)
| |